Загрузка...
Galantamine Activates Muscle-Type Nicotinic Acetylcholine Receptors without Binding to the Acetylcholine-Binding Site
Galantamine (Reminyl; Janssen Pharmaceutica, Titusville, NJ) belongs to a class of acetylcholinesterase inhibitors approved for symptomatic treatment of Alzheimer's disease. The drug presumably acts by raising and prolonging the profile of acetylcholine (ACh) via an inhibitory effect on the est...
Сохранить в:
| Опубликовано в: : | J Neurosci |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society for Neuroscience
2005
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726061/ https://ncbi.nlm.nih.gov/pubmed/15728839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4985-04.2005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|